← Eichor
Study identifier: NCT05429632 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Condition: Adult Acute Myeloid Leukemia  ·  Sponsor: Priothera SAS

PhasePhase 3
Planned participants366
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a multi-center, randomized, double-blinded, placebo controlled trial.

This description comes directly from the study's public registry record.

Talk to the study team

Malika Souquieres, MSc  ·  +33 (0) 6 40 91 26 76  ·  malika.souquieres@priothera.com

Jens Hasskarl, MD  ·  +41 79 5432099  ·  jens.hasskarl@priothera.com

Always discuss trial participation with your own doctor first.

Locations (111)

University of Alabama Hospital (UAB Hospital)Birmingham, Alabama, United StatesActive Not Recruiting
Banner MD Anderson Cancer CenterGilbert, Arizona, United StatesWithdrawn
City of Hope Comprehensive Cancer Center - DuarteDuarte, California, United StatesRecruiting
University of California Los Angeles (UCLA) - David Geffen School of MedicineLos Angeles, California, United StatesRecruiting
UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer CenterAurora, Colorado, United StatesWithdrawn
Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
Emory University - Winship Cancer Institute (WCI)Atlanta, Georgia, United StatesRecruiting
University of Iowa Hospitals and ClinicsIowa City, Iowa, United StatesRecruiting
University of Kansas Cancer CenterWestwood, Kansas, United StatesRecruiting
Ochsner Medical Center (OMC) - New OrleansNew Orleans, Louisiana, United StatesWithdrawn
University of Maryland Medical Center (UMMC)Baltimore, Maryland, United StatesRecruiting
Massachusetts General HospitalBoston, Massachusetts, United StatesWithdrawn

+ 99 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05429632